Navigation Links
SEE ALGAE Technology GmbH Announces Sale of Algae Farm to Brazil's Grupo JB

VIENNA, June 19, 2012 /PRNewswire/ -- SEE ALGAE Technology GmbH ("SAT" or the "Company"), a leading developer of infrastructure for the commercial production of high-quality algae, announced today that it had signed an agreement to supply and install a 1 hectare "dual-use" algae production plant for Recife, Brazil-based Grupo JB ("JB"), one of the leading bioethanol producers in Brazil. Once operational, this farm will primarily be utilized to produce algae biomass and bioethanol from both natural and genetically modified algae strains. Algae biomass is used as a replacement for soybean meal in feed for livestock and fish. This production process will also yield algae lipids which can be used to make biodiesel and certain biochemicals, among other compounds.

Under the 8 million euro agreement, SAT will design an algae farm and provide its algae cultivation technology to JB, oversee the farm's installation, and ensure the farm's initial productivity.

Separately, SAT has also entered into a joint venture (JV) with Grupo JB to market the Company's algae production technology in Brazil. The JV, "ALGAS DO BRASIL," will make use of JB's extensive commercial contact network to enhance SAT's marketing efforts. ALGAS DO BRASIL will be 63% owned by SAT and 37% owned by JB.

"We are truly proud to have Grupo JB as not only the first commercial customer for our micro-algae production technology, but also as a strategic marketing partner," said Dr. Joachim Grill, CEO of SEE ALGAE Technology. "We believe," he continued, "that this marks a significant step forward in the evolution of our Company and validates both our exclusive technology and the commercial viability of algae, especially for use in feed and biofuels. With Grupo JB as our strategic partner in Brazil, we expect to take a leadership position in this exciting technology."

About SEE ALGAE Technology GmbH

SEE ALGAE Technology GmbH (SAT), based in Vienna, Austria, develops infrastructure for the commercial production of high-quality algae used to manufacture livestock feed, bioethanol and biodiesel fuel.  SAT's proprietary, patented technology is easily scaled to meet customers' needs and has the highest production yield and lowest operating cost of any currently available commercial process.


Company Contact:

SEE ALGAE Technology GmbH

Dr. Joachim Grill, CEO

Phone: +43 1 985 9802 0



Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Algae Farm (USA) Patent Update
2. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
3. Algae.Tec Announces Commencement of Australian Advanced Biofuels Facility Commissioning
4. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
5. DNA Blood Test Detects Cancer Resistance Using Inostics BEAMing Technology
6. Biotechnology and Environmental Protection at this Years ACHEMA
7. Choose New Jersey, Inc. to Tout New Jerseys Life Sciences Hub At Worlds Largest Biotechnology Event
8. Syracuse University researchers use nanotechnology to harness power of fireflies
9. Life Technologies Signs Licensing Agreement with iPS Academia Japan for Global Patent Portfolio Rights to Induced Pluripotent Stem Cell Technology
10. Cohera Medical Awarded Platform Patent on its Biodegradable Adhesive Technology
11. Taking solar technology up a notch
Post Your Comments:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/22/2016)... PUNE, India , March 22, 2016 ... new market research report "Electronic Sensors Market for ... Fingerprint, Proximity, & Others), Application (Communication & ... and Geography - Global Forecast to 2022", ... consumer industry is expected to reach USD ...
Breaking Biology News(10 mins):